CRISPR Therapeutics
company in Basel, Switzerland
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 11 annual filings
Revenue
$3.51M
Net Income
-$581.60M
Assets
$2.27B
EPS (diluted)
$-6.47
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2025-12-31 · accession
0001193125-26-048957CRISPR Therapeutics
Summary
CRISPR Therapeutics is a business[1]. It ranks in the top 3% of business entities by monthly Wikipedia readership (537 views/month).[2]
Key Facts
- CRISPR Therapeutics is in the country of Switzerland[3].
- CRISPR Therapeutics is in the country of CH[4].
- CRISPR Therapeutics's instance of is recorded as business[5].
- CRISPR Therapeutics's instance of is recorded as company[6].
- CRISPR Therapeutics's instance of is recorded as public company[7].
- CRISPR Therapeutics's founder is recorded as Emmanuelle Charpentier[8].
- CRISPR Therapeutics's headquarters location is recorded as Zug[9].
- CRISPR Therapeutics's stock exchange is recorded as Nasdaq[10].
- CRISPR Therapeutics's industry is recorded as biotechnology industry[11].
- January 1, 2013 marks the founding of CRISPR Therapeutics[12].
- 2013-10-31 marks the founding of CRISPR Therapeutics[13].
- CRISPR Therapeutics's official website is recorded as http://www.crisprtx.com/[14].
- CRISPR Therapeutics's legal form is recorded as Aktiengesellschaft[15].
- CRISPR Therapeutics's legal form is recorded as MVII[16].
- CRISPR Therapeutics's social media followers is recorded as {'amount': '+11414'}[17].
- CRISPR Therapeutics's social media followers is recorded as {'amount': '+17415'}[18].
- CRISPR Therapeutics's social media followers is recorded as {'amount': '+19367'}[19].
Body
Founding
CRISPR Therapeutics's founder is recorded as Emmanuelle Charpentier[8]. Recorded inception include January 1, 2013[12] and 2013-10-31[13].
Operations
CRISPR Therapeutics's headquarters location is recorded as Zug[9].
Industry
CRISPR Therapeutics's industry is recorded as biotechnology industry[11].
Ownership
CRISPR Therapeutics's stock exchange is recorded as Nasdaq[10].
Why It Matters
CRISPR Therapeutics ranks in the top 3% of business entities by monthly Wikipedia readership (537 views/month).[2]